0001613377-18-000013.txt : 20180719 0001613377-18-000013.hdr.sgml : 20180719 20180719135000 ACCESSION NUMBER: 0001613377-18-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180718 FILED AS OF DATE: 20180719 DATE AS OF CHANGE: 20180719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RODINO III PETER W. CENTRAL INDEX KEY: 0001583701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-27072 FILM NUMBER: 18960209 MAIL ADDRESS: STREET 1: 860 N. ORANGE AVENUE STREET 2: SUITE B CITY: ORLANDO STATE: FL ZIP: 32801 FORMER NAME: FORMER CONFORMED NAME: Rodino Peter W. III DATE OF NAME CHANGE: 20130805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 860 N. ORANGE AVENUE STREET 2: SUITE B CITY: ORLANDO STATE: FL ZIP: 32801 BUSINESS PHONE: 407-271-8516 MAIL ADDRESS: STREET 1: 860 N. ORANGE AVENUE STREET 2: SUITE B CITY: ORLANDO STATE: FL ZIP: 32801 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-07-18 0 0000946644 HEMISPHERX BIOPHARMA INC HEB 0001583701 RODINO III PETER W. 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 0 1 0 0 Dir Govt Relations/Sectry Options to buy Common Stock 0.31 2018-07-18 4 A 0 75269 0 A 2018-07-18 2028-07-18 Common Stock 75269 75269 D This option is being issued to senior management in exchange for a voluntary 40% deferral in salary. Peter W. Rodino 2018-07-19